1832 Asset Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
HL
1832 Asset Management's GMAB Position: Q4 2023 in Review
1832 Asset Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 2,243,600 shares — an estimated $79.1M sold.
1832 Asset Management first reported a position in GMAB in Q1 2020 and held it in 15 quarters. The position peaked at $96.9M in Q4 2022. 226 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.
- 1832 Asset Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
- 1832 Asset Management sold 2,243,600 Genmab shares in Q4 2023, an estimated $79.1M.
- 1832 Asset Management first reported a position in Genmab in Q1 2020 and held it in 15 quarters.
- 1832 Asset Management's Genmab position peaked at $96.9M in Q4 2022.
- 226 funds tracked by Wall St. Rank held Genmab as of Q4 2023.
Based on 1832 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.